All Title Author
Keywords Abstract

Publish in OALib Journal
ISSN: 2333-9721
APC: Only $99

ViewsDownloads

Malaria Surveillance at the Patent Medicine Vendors: A Pilot Study in Jigawa State, Nigeria

DOI: 10.4236/oalib.1106641, PP. 1-10

Subject Areas: Infectious Diseases, Epidemiology

Keywords: Malaria Elimination, Patent Medicine Vendors, mRDT, ACT, Jigawa, Suspected Fever, Nigeria

Full-Text   Cite this paper   Add to My Lib

Abstract

Background: In Nigeria, the 2018 world malaria report shows that the country’s malaria surveillance system detects less than 20 per cent of the total malaria case. In malaria control programmes, the main source of data is health facility-based and reported routinely through the health information systems. The collected data is mainly for monitoring and evaluation at the programmatic level. Although the adoption of the District Health Information Software (DHIS2) has greatly improved the availability of routine data from health facilities, much is being missed out in the developing countries. And this is because a sizeable number of malaria cases ends up at the formal and non-formal patent medicine vendors (PMVs), thus raising questions about the representativeness of the data collected through the routine DHIS2. Methods: This pilot study, using a quantitative cross-sectional study, attempted to assess malaria surveillance at the PMVs. Three local government areas (LGAs) of Jigawa state, northwestern Nigeria were randomly selected at one LGA from each of the three senatorial districts of the state. Using SPSS statistical application version 24, the study looked at suspected malaria cases across the LGAs. Also, it assessed causal relationships between the RDT testing for suspected malaria and treatment using the ACTs at the PMVs. The eligible participants were children and adults across the two genders with suspected malaria using fever as the entry point. The study collected data for suspected malaria cases between 1st September and 30th November 2019. Results: The analyses show that a total of 9080 suspected fever cases reported in 22 wards across the 3 selected LGAs (Dutse, Ringim, and Kafin Hausa). The disaggregated data shows Dutse reported 2328 (25.64%), Ringim 3515 (38.71%), and K/Hausa 3237 (35.65%) cases. The Pearson Correlation 1.000, (α = 0.01, p < 0.05) 2-tailed test showed a positive linear relationship between suspected malaria cases at the PMVs who get mRDT test and treatment using the ACTs. The Null Hypothesis, which stated that there is no correlation between ACT treatment and suspected malaria cases at the patent medicine vendors (PMVs) tested using mRDT, was rejected in favor of the Alternative Hypothesis. Conclusion: This study underscores the need for malaria control programmes at all levels to incorporate the PMVs in the routine reporting system through the DHIS2 platform. This approach would go a long way to improve the country’s malaria surveillance system, channel the meagre resources to effectively reduce malaria morbidity and mortality, and help in attaining the malaria-free status.

Cite this paper

Saleh, J. A. , Saddiq, A. , Mpazanje, R. , Ozor, L. , Bulangu, U. G. , Babatunde, S. , Nglass, I. , Edeh, E. , Shuaib, N. and Onoh, M. (2020). Malaria Surveillance at the Patent Medicine Vendors: A Pilot Study in Jigawa State, Nigeria. Open Access Library Journal, 7, e6641. doi: http://dx.doi.org/10.4236/oalib.1106641.

References

[1]  WHO (2012) Disease Surveillance for Malaria Control: An Operational Manual.
[2]  WHO (2006) Partnerships for Malaria Control: Engaging the Formal and Informal Private Sectors. Geneva.
[3]  UNICEF (2015) Achieving the Malaria MDG Target. https://www.unicef.org/reports/achieving-malaria-mdg-target
[4]  Githinji, S., Oyando, R., Malinga, J., et al. (2017) Completeness of Malaria Indicator Data Reporting via the District Health Information Software 2 in Kenya, 2011-2015. Malaria Journal, 16, 344. https://doi.org/10.1186/s12936-017-1973-y
[5]  Berendes, S., Adeyemi, O., Oladele, E.A., Oresanya, O.B., et al. (2012) Are Patent Medicine Vendors Effective Agents in Malaria Control? Using Lot Quality Assurance Sampling to Assess Quality of Practice in Jigawa, Nigeria. PLoS ONE, 7, e44775. https://doi.org/10.1371/journal.pone.0044775
[6]  Akuse, R.M., Eseigbe, E.E., Ahmed, A. and Brieger, W.R. (2010) Patent Medicine Sellers: How Can They Help Control Childhood Malaria? Malaria Research and Treatment, 2010, Article ID: 470754. https://doi.org/10.4061/2010/470754
[7]  WHO (2018) Malaria Surveillance, Monitoring & Evaluation: A Reference Manual.
[8]  Benjamin, S.C., Uzochukwu, O.P., Emma-Ukaegbu, E.U., Onwujekwe, O.E., et al. (2010) Malaria Treatment Services in Nigeria: A Review. Nigerian Medical Journal, 51, 114-119.
[9]  WHO (2018) World Malaria Report 2018. https://www.who.int/malaria/publications/world-malaria-report-2018/en
[10]  Ajzen, I. and Fishbein, M. (1980) Understanding Attitudes and Predicting Social Behavior. Prentice-Hall, Englewood Cliffs.
[11]  Glanz, K., Rimer, B.K. and Viswanath, K. (2008) Health Behavior and Health Education: Theory, Research, and Practice. 4th Edition, John Wiley and Sons, San Francisco.
[12]  Salako, L.A., Brieger, W.R., Afolabi, B.M., et al. (2001) Treatment of Childhood Fevers and Other Illnesses in Three Rural Nigerian Communities. Journal of Tropical Pediatrics, 47, 230-238. https://doi.org/10.1093/tropej/47.4.230
[13]  Snow, R.W., Peshu, N., Forster, D., Mwenesi, H. and Marsh, K. (1992) The Role of Shops in the Treatment and Prevention of Childhood Malaria on the Coast of Kenya. Transactions of the Royal Society of Tropical Medicine and Hygiene, 86, 237-239. https://doi.org/10.1016/0035-9203(92)90290-S
[14]  Goodman, C., Brieger, W., Unwin, A., Mills, A., Meek, S. and Greer, G. (2007) Medicine Sellers and Malaria Treatment in Sub-Saharan Africa: What do They Do and How Can Their Practice Be Improved? The American Journal of Tropical Medicine and Hygiene, 77, 203-218. https://doi.org/10.4269/ajtmh.2007.77.203
[15]  van der Geest, S. (1987) Self-Care and the Informal Sale of Drugs in South Cameroon. Social Science and Medicine, 25, 293-305. https://doi.org/10.1016/0277-9536(87)90232-2
[16]  Onwujekwe, O. (2005) Inequities in Healthcare Seeking in the Treatment of Communicable Endemic Diseases in Southeast Nigeria. Social Science and Medicine, 61, 455-463. https://doi.org/10.1016/j.socscimed.2004.11.066
[17]  Strategies for Enhancing Access to Medicines (SEAM)—in Proceedings of the Targeting Improved Access to Essential Medicine Conference, Accra, Ghana, June 2005. https://www.msh.org/news-events/stories/improving-access-to-medicines-for-all
[18]  Brugha, R. and Zwi, A. (1998) Improving the Quality of Private Sector Delivery of Public Health Services: Challenges and Strategies. Health Policy and Planning, 13, 107-120. https://doi.org/10.1093/heapol/13.2.107
[19]  Raynal, A.L. (1985) Use of Over-the-Counter Medications in Rural Matabeleland, Zimbabwe: The Case for Upgrading the Dispensing Skills of Rural Storekeepers. Central African Journal of Medicine, 31, 92-97.
[20]  Oshiname, F.O. and Brieger, W.R. (1992) Primary Care Training for Patent Medicine Vendors in Rural Nigeria. Social Science and Medicine, 35, 1477-1484. https://doi.org/10.1016/0277-9536(92)90050-Z
[21]  Tawfik, Y., Northrup, R. and Prysor-Jone, S. (2002) Utilizing the Potential of Formal and Informal Private Practitioners in Child Survival: Situation Analysis and Summary of Promising Interventions. Tech. Rep., Support for Analysis and Research in Africa (SARA) Project, Academy for Educational Development, Washington DC. http://pdf.usaid.gov/pdf_docs/PNACP202.pdf
[22]  Adinma, E.D. and Adinma, B.J. (2010) Community Based Healthcare Financing: An Untapped Option to Effective Healthcare Funding in Nigeria. Nigerian Medical Journal, 51, 95-100.
[23]  Sekhri, N. and Savedoff, W. (2005) Private Health Insurance: Implications for Developing Countries. Bulletin of the World Health Organization, 83, 127-134.
[24]  Carrin, G., Mathauer, I., Xu, K. and Evans, D.B. (2008) Universal Coverage of Health Services: Tailoring Its Implementation. Bulletin of the World Health Organization, 86, 857-863. https://doi.org/10.2471/BLT.07.049387
[25]  Evans, D.B., Carrin, G. and Evans, T.G. (2005) The Challenge of Private Insurance for Public Good. Bulletin of the World Health Organization, 83, 83.
[26]  Preker, A.S., Carrin, G., Dror, D., Jakab, M., Hsiao, W. and Arhin-Tenkorang, D. (2002) Effectiveness of Community Health Financing in Meeting the Cost of Illness. Bulletin of the World Health Organization, 80, 143-150.
[27]  Poletti, T., Balabanova, D., Ghazaryan, O., Kamal-Yanni, M., Kocharyan, H., Arakelyan, K. and Hakobyan, M. (2007) Options for Scaling Up Community-Based Health Insurance for Rural Communities in Armenia. Health Systems Development. London School of Hygiene and Tropical Medicine, London.
[28]  Polonsky, J., Balabanova, D., McPake, B., Poletti, T., Vyas, S., Ghazaryan, O. and Yanni, M.K. (2009) Equity in Community Health Insurance Schemes: Evidence and Lessons from Armenia. Health Policy Plan, 24, 209-216. https://doi.org/10.1093/heapol/czp001

Full-Text


comments powered by Disqus

Contact Us

service@oalib.com

QQ:3279437679

微信:OALib Journal